Argentina vs Egypt: The number of people with susceptibility test result for rifampicin
Argentina
2,309
in 2021
Egypt
2,962
in 2021
Argentina rank
44th
Egypt rank
41st
The number of people with susceptibility test result for rifampicin over time
- Argentina
- Egypt
How they compare
Egypt currently reports 2,962 against 2,309 in Argentina, a difference of 653.
That makes Egypt's figure about 1.3 times Argentina's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Argentina ahead.
Argentina ranks 44th and Egypt ranks 41st of 155 countries.
Egypt has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,204 | 2,475 | 1,271 | Egypt |
| 2020s | 1,732 | 2,888 | 1,156 | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Argentina or Egypt?
- Egypt, at 2,962 against 2,309 in Argentina as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Argentina and Egypt?
- 653, with Egypt ahead.
- How many years of comparable data are there for Argentina and Egypt?
- 5 years are reported by both, from 2017 to 2021.
- How do Argentina and Egypt rank globally for the number of people with susceptibility test result for rifampicin?
- Argentina ranks 44th and Egypt ranks 41st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.